BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24298311)

  • 1. Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine.
    Wong WT; Sayed N; Cooke JP
    Methodist Debakey Cardiovasc J; 2013; 9(4):206-9. PubMed ID: 24298311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.
    Csöbönyeiová M; Polák Š; Danišovič L
    Exp Biol Med (Maywood); 2015 May; 240(5):549-56. PubMed ID: 25595188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steps toward safe cell therapy using induced pluripotent stem cells.
    Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
    Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.
    Nsair A; MacLellan WR
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):324-30. PubMed ID: 21371511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells for cardiac repair.
    Zwi-Dantsis L; Gepstein L
    Cell Mol Life Sci; 2012 Oct; 69(19):3285-99. PubMed ID: 22960788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogrammed cells for disease modeling and regenerative medicine.
    Cherry AB; Daley GQ
    Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
    Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells.
    Sugiura T; Shahannaz DC; Ferrell BE
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iPSCs, aging and age-related diseases.
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?
    Tohyama S; Fukuda K
    Circ Res; 2017 May; 120(10):1558-1560. PubMed ID: 28495993
    [No Abstract]   [Full Text] [Related]  

  • 16. Induced pluripotent stem cells in research and therapy.
    Teoh HK; Cheong SK
    Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Role of Induced Pluripotent Stem Cells as Regenerative Medicine in Retinal Cell Damage.
    Sun YJ; Pan YR; Fan B; Li GY
    J Environ Pathol Toxicol Oncol; 2018; 37(4):305-316. PubMed ID: 30806237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iPS cell technologies and cartilage regeneration.
    Tsumaki N; Okada M; Yamashita A
    Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.